Traditional Chinese medicine industry in kunming "consultation" innovation and development path

Time: 2016-11-29

Source: xinhua

Author: Han Haikuo

Xinhuanet kunming on November 27 (Han Haikuo) 27, 2016 innovative Chinese medicine and plant medicine international summit held four points BBS, well-known experts in the domestic industry, scientific research institutions, hospital, entrepreneurs representatives continue to operate around the industrial policy, strategy, product development, market investment and in-depth exchanges and widely discussed.

2016 innovative Chinese medicine and plant medicine international summit kicks off in 26, the activity by the state (Shanghai) innovation center for TCM modernization, China's pharmaceutical industry information center, department of yunnan province, yunnan, yunnan in the new district management committee jointly organized. 27 the four points of BBS, respectively in order to "technology and application" "the trend of the market and choose" fusion and innovation of "industry" the layout and the prospects of "capital" as the theme.

In reference to the development and application of herbal medicine genomics, a researcher at the Chinese institute of traditional Chinese medicine academy of sciences, said Chen sl, which revolves around medica genomics studies, reveal the active ingredients of salvia miltiorrhiza genome synthesis pathway, notoginseng group study to speed up the mature and stable of new subject, promoted the related traditional Chinese medicinal materials cultivation and planting. He pointed out that some Chinese herbal medicine on the market at present identification difficult, need to seek breakthrough from the genetic method, make appraisal bid farewell to traditional Chinese medicinal materials "mouth" knowledge, into the general and standardized era of gene identification.

Development of traditional Chinese medicine, we must rely on the strength of technology innovation and scientific research. Research and development of innovative research and development center of yunnan baiyao group director, director of the institute, yunnan drug Zhu Zhaoyun also said that China's national medicine is like a mountain flower, it is because of the particularity of its effectiveness, and traditional medicine yi yi is unripe brightness, but the folk medicine to seek development, must break the basic research is weak, the scientific research level is limited and the shortage of working on the research and development personnel bottlenecks.

It is understood that at present, yunnan has basically formed, with emphasis on the natural medicine (traditional Chinese medicine (TCM) national medicine) r&d and production of Chinese herbal medicine planting and processing, biological medicine, and health care products production, health care services, commerce and trade circulation system composed of biological medicine health industry.

Biological pharmaceutical and health industry in yunnan province, deputy director of the office of the TuiJinZu Hu Qixiang speech, vice President of the school of science and technology, yunnan province, said the development of biomedicine and health industry in yunnan province will revolve around biological medicine, health products, medical equipment, medical service, health care, health management in six fields.

"Much starker choices-and graver consequences-in" biological pharmaceutical and health industry development in yunnan province to do big stock, introducing total increment, expand as the main line, to foster large enterprises, the development of great varieties, build brands, build base as the goal, key quality raw material industry, biological medicine, biological medicine industrial, medical and health services business four areas industry development, the implementation of "147" (a center, the four bases, seven engineering) development strategy. By 2020, strive to achieve the main business income reached 380 billion yuan, including biological medicine planting (breeding) industry and industry the main business income reached 150 billion yuan.